Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Op-Eds
Upstream Battle for Genetically Engineered Salmon
Over the last two decades, the use of modern genetic engineering technology to produce pharmaceuticals and new crop plants has given rise to prodigious scientific,…
Op-Eds
Don’t Blame BPA on Lobster Decline
If you trust the headlines, you might think that the biggest challenge facing the lobster industry in New York and New England is pollution —…
Citation
USA – The billion dollar drug lobby in overdrive
Citation
Call Made for Continued Use of Antibiotics
Citation
CEI Backs Judicious Antimicrobial Use in Livestock
Comment
CEI Comments regarding FDA’s Draft Guidance on the Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals
Executive Summary The Competitive Enterprise Institute respectfully submits these comments on the agency’s Draft Guidance on The Judicious Use of Medically Important Antimicrobial…